Letter to the Editor: Unanswered questions about hepatitis B virus infection in patients with COVID‐19

Xiu‐He Lv,Jin‐Lin Yang,Kai Deng

DOI: https://doi.org/10.1002/hep.32098

IF: 17.298

2021-12-07

Hepatology

Abstract:We read with great interest of the study written by Yip et al (1). The authors answered some previously unanswered questions about COVID-19 patients with hepatitis B virus (HBV) infection and thus had clear clinical implications. We think some questions still need to be answered further on this topic.The primary endpoint of this study was all-cause mortality. Notably, the severity of disease in COVID-19 patients was not discussed. The results of current studies on whether HBV infection increases disease severity in patients with COVID-19 have been inconsistent, even in some studies with large samples from China (2,3).

gastroenterology & hepatology